Glg Life Tech Corp (GLGLF) 0.2680 $GLGLF
GLG Announces FDA's Issuance of Letter of No Objection for High-Purity Rebaudioside C Blends & Becomes First to Market With GRAS Reb C Product Offerings
GlobeNewswire - Tue Feb 17, 6:58AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Letter of No Objection for GLG's high-purity Rebaudioside C ("Reb C" stevia extract where used as a general purpose sweetener in blends containing Rebaudioside A ("Reb A" and from 10% to 50% Reb C. (Filing No. GRN 536). GLG submitted its application pursuant to the FDA's GRAS program, and is the first company to receive a Letter of No Objection from the FDA for a high-purity Reb C product certified under the GRAS process. This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, in which GLG, through in-depth consultation with GRAS Associates, LLC, reported the results of its extensive studies and its conclusion that Rebaudioside C is Generally Recognized as Safe ("GRAS".
GLG.TO: 0.34 (+0.01)
GLG Develops New "Super" Reb A Seedling, Nearly Tripling the Amount of Rebaudioside A
GlobeNewswire - Mon Dec 15, 6:39AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company" announces today another major agricultural breakthrough. Through its non-GMO 2014 agricultural program, GLG has developed a new stevia seedling variety that is expected to decrease the cost of producing high-purity Rebaudioside A ("Reb A" or "RA" stevia extracts by 50% to 60%. Dubbed the "Super RA" or "SRA" variety, this strain contains double the amount of Total Steviol Glycosides ("TSG" and nearly triple the amount of Reb A glycosides than contained in conventional stevia leaf on the market today.
GLG.TO: 0.34 (+0.01)
GLG Announces FDA'S Issuance of Letter of No Objection for Luo Han Guo (Monk Fruit) Extracts
GlobeNewswire - Wed Dec 10, 6:30AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company", a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Generally Recognized as Safe letter of no objection for GLG's Luo Han Guo (Monk Fruit) extract products. (Filing No. GRN 522). This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, which covers three distinct Luo Han Guo extracts -- MV30, MV50, and MV60 -- each containing a minimum level of mogroside V (30%, 50%, and 60%, respectively).
GLG.TO: 0.34 (+0.01)
GLG Patents New Rebaudioside C Seedling With 600% More Rebaudioside C Than Traditional Stevia Plants -- Paves the Way for High Volume / Lower Cost Natural Rebaudioside C Extracts
GlobeNewswire - Tue Dec 09, 8:12AM CST
GLG (TSX:GLG) ("GLG" or the "Company" announces today a major agricultural breakthrough, one that could revolutionize the global food and beverage industry's ability to utilize naturally-sourced Rebaudioside C ("Reb C". Through GLG's development of its H6 seedling using its non-GMO patented breeding methodology, the GLG agriculture team has developed a new strain containing remarkably high levels of Reb C glycosides. Historically, conventional stevia leaf has had Reb C concentrations of around 1%. Now, GLG's H6 strain contains Reb C concentrations verging on 7%. Lab tests show that Reb C comprises 53% of the glycosides in the H6 leaf, compared to values of 6% to 8% in other strains of stevia leaf - a 600% increase.
GLG.TO: 0.34 (+0.01)
GLG Announces FDA's Issuance of Letter of No Objection for High-Purity Rebaudioside M
GlobeNewswire - Mon Oct 27, 6:30AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company", a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Generally Recognized as Safe letter of no objection for its high-purity Rebaudioside M stevia extract product. (Filing No. GRN 512). This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, in which GLG, through in-depth consultation with GRAS Associates, LLC, reported the results of its studies and its conclusion that Rebaudioside M is Generally Recognized as Safe ("GRAS".
GLG.TO: 0.34 (+0.01)
GLG Announces GRAS Notification With FDA for High-Purity Rebaudioside D
GlobeNewswire - Thu Oct 02, 6:30AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company", a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that it has submitted a Generally Recognized as Safe ("GRAS" notification with the United States Food and Drug Administration ("FDA" for its high-purity Rebaudioside D stevia extract product. This notification represents many months of work to develop the product and all required documentation under the FDA-administered GRAS process to demonstrate that GLG's Rebaudioside D extract meets the FDA's criteria for safety. This included in-depth consultation with GRAS Associates, LLC, who convened an independent panel of scientists to spearhead this safety assessment.
GLG.TO: 0.34 (+0.01)
GLG Announces Discontinuance of Final Pending Shareholder Lawsuit
GlobeNewswire - Tue Sep 30, 7:31AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company", a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the Ontario Superior Court of Justice has ordered that the lone remaining shareholder lawsuit brought against GLG be discontinued. With the prior discontinuance of a similar action brought in the Supreme Court of British Columbia, the Ontario court's order brings an end to the Canadian shareholder lawsuits.
GLG.TO: 0.34 (+0.01)
GLG Announces Changes to Convertible Debt Agreement
GlobeNewswire - Fri Sep 12, 7:00AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company", a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that it has finalized an agreement that is expected to result in conversion of a $4.3 million obligation into shares in the Company. The obligation originated with GLG's disposition of its interest in the AN0C joint venture. Pursuant to that disposition, on September 30, 2013, GLG issued a three-year convertible note to China Agricultural Healthy Foods Limited ("CAHFC" with a principal amount of CAD $4,295,532.65 due September 30, 2016, or convertible into common shares of GLG at $1.80 per share.
GLG.TO: 0.34 (+0.01)
GLG Announces FDA's Issuance of Letter of No Objection for High-Purity Rebaudioside C Blends & Becomes First to Market With GRAS Reb C Product Offerings
GlobeNewswire - Tue Feb 17, 6:58AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality zero-calorie natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Letter of No Objection for GLG's high-purity Rebaudioside C ("Reb C" stevia extract where used as a general purpose sweetener in blends containing Rebaudioside A ("Reb A" and from 10% to 50% Reb C. (Filing No. GRN 536). GLG submitted its application pursuant to the FDA's GRAS program, and is the first company to receive a Letter of No Objection from the FDA for a high-purity Reb C product certified under the GRAS process. This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, in which GLG, through in-depth consultation with GRAS Associates, LLC, reported the results of its extensive studies and its conclusion that Rebaudioside C is Generally Recognized as Safe ("GRAS". GLG.TO: 0.34 (+0.01)
GLG Develops New "Super" Reb A Seedling, Nearly Tripling the Amount of Rebaudioside A
GlobeNewswire - Mon Dec 15, 6:39AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
announces today another major agricultural breakthrough. Through its non-GMO 2014 agricultural program, GLG has developed a new stevia seedling variety that is expected to decrease the cost of producing high-purity Rebaudioside A ("Reb A" or "RA" stevia extracts by 50% to 60%. Dubbed the "Super RA" or "SRA" variety, this strain contains double the amount of Total Steviol Glycosides ("TSG" and nearly triple the amount of Reb A glycosides than contained in conventional stevia leaf on the market today. GLG.TO: 0.34 (+0.01)
GLG Announces FDA'S Issuance of Letter of No Objection for Luo Han Guo (Monk Fruit) Extracts
GlobeNewswire - Wed Dec 10, 6:30AM CST
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Generally Recognized as Safe letter of no objection for GLG's Luo Han Guo (Monk Fruit) extract products. (Filing No. GRN 522). This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, which covers three distinct Luo Han Guo extracts -- MV30, MV50, and MV60 -- each containing a minimum level of mogroside V (30%, 50%, and 60%, respectively). GLG.TO: 0.34 (+0.01)
GLG Patents New Rebaudioside C Seedling With 600% More Rebaudioside C Than Traditional Stevia Plants -- Paves the Way for High Volume / Lower Cost Natural Rebaudioside C Extracts
GlobeNewswire - Tue Dec 09, 8:12AM CST
GLG (TSX:GLG) ("GLG" or the "Company"
announces today a major agricultural breakthrough, one that could revolutionize the global food and beverage industry's ability to utilize naturally-sourced Rebaudioside C ("Reb C". Through GLG's development of its H6 seedling using its non-GMO patented breeding methodology, the GLG agriculture team has developed a new strain containing remarkably high levels of Reb C glycosides. Historically, conventional stevia leaf has had Reb C concentrations of around 1%. Now, GLG's H6 strain contains Reb C concentrations verging on 7%. Lab tests show that Reb C comprises 53% of the glycosides in the H6 leaf, compared to values of 6% to 8% in other strains of stevia leaf - a 600% increase. GLG.TO: 0.34 (+0.01)
GLG Announces FDA's Issuance of Letter of No Objection for High-Purity Rebaudioside M
GlobeNewswire - Mon Oct 27, 6:30AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the United States Food and Drug Administration ("FDA" has issued a Generally Recognized as Safe letter of no objection for its high-purity Rebaudioside M stevia extract product. (Filing No. GRN 512). This letter confirms that the FDA has no questions regarding GLG's GRAS notice submitted earlier this year, in which GLG, through in-depth consultation with GRAS Associates, LLC, reported the results of its studies and its conclusion that Rebaudioside M is Generally Recognized as Safe ("GRAS". GLG.TO: 0.34 (+0.01)
GLG Announces GRAS Notification With FDA for High-Purity Rebaudioside D
GlobeNewswire - Thu Oct 02, 6:30AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that it has submitted a Generally Recognized as Safe ("GRAS" notification with the United States Food and Drug Administration ("FDA" for its high-purity Rebaudioside D stevia extract product. This notification represents many months of work to develop the product and all required documentation under the FDA-administered GRAS process to demonstrate that GLG's Rebaudioside D extract meets the FDA's criteria for safety. This included in-depth consultation with GRAS Associates, LLC, who convened an independent panel of scientists to spearhead this safety assessment. GLG.TO: 0.34 (+0.01)
GLG Announces Discontinuance of Final Pending Shareholder Lawsuit
GlobeNewswire - Tue Sep 30, 7:31AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that the Ontario Superior Court of Justice has ordered that the lone remaining shareholder lawsuit brought against GLG be discontinued. With the prior discontinuance of a similar action brought in the Supreme Court of British Columbia, the Ontario court's order brings an end to the Canadian shareholder lawsuits. GLG.TO: 0.34 (+0.01)
GLG Announces Changes to Convertible Debt Agreement
GlobeNewswire - Fri Sep 12, 7:00AM CDT
GLG Life Tech Corporation (TSX:GLG) ("GLG" or the "Company"
, a global leader in the agricultural and commercial development of high-quality natural sweeteners, is pleased to announce that it has finalized an agreement that is expected to result in conversion of a $4.3 million obligation into shares in the Company. The obligation originated with GLG's disposition of its interest in the AN0C joint venture. Pursuant to that disposition, on September 30, 2013, GLG issued a three-year convertible note to China Agricultural Healthy Foods Limited ("CAHFC" with a principal amount of CAD $4,295,532.65 due September 30, 2016, or convertible into common shares of GLG at $1.80 per share. GLG.TO: 0.34 (+0.01)
